Literature DB >> 24719089

Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down's syndrome.

Gurjinder Kaur1, Ajay Sharma, Wenjin Xu, Scott Gerum, Melissa J Alldred, Shivakumar Subbanna, Balapal S Basavarajappa, Monika Pawlik, Masuo Ohno, Stephen D Ginsberg, Donald A Wilson, David N Guilfoyle, Efrat Levy.   

Abstract

Trisomy 21, or Down's syndrome (DS), is the most common genetic cause of intellectual disability. Altered neurotransmission in the brains of DS patients leads to hippocampus-dependent learning and memory deficiency. Although genetic mouse models have provided important insights into the genes and mechanisms responsible for DS-specific changes, the molecular mechanisms leading to memory deficits are not clear. We investigated whether the segmental trisomy model of DS, Ts[Rb(12.1716)]2Cje (Ts2), exhibits hippocampal glutamatergic transmission abnormalities and whether these alterations cause behavioral deficits. Behavioral assays demonstrated that Ts2 mice display a deficit in nest building behavior, a measure of hippocampus-dependent nonlearned behavior, as well as dysfunctional hippocampus-dependent spatial memory tested in the object-placement and the Y-maze spontaneous alternation tasks. Magnetic resonance spectra measured in the hippocampi revealed a significantly lower glutamate concentration in Ts2 as compared with normal disomic (2N) littermates. The glutamate deficit accompanied hippocampal NMDA receptor1 (NMDA-R1) mRNA and protein expression level downregulation in Ts2 compared with 2N mice. In concert with these alterations, paired-pulse analyses suggested enhanced synaptic inhibition and/or lack of facilitation in the dentate gyrus of Ts2 compared with 2N mice. Ts2 mice also exhibited disrupted synaptic plasticity in slice recordings of the hippocampal CA1 region. Collectively, these findings imply that deficits in glutamate and NMDA-R1 may be responsible for impairments in synaptic plasticity in the hippocampus associated with behavioral dysfunctions in Ts2 mice. Thus, these findings suggest that glutamatergic deficits have a significant role in causing intellectual disabilities in DS.

Entities:  

Keywords:  Down's syndrome; LTP; NMDA receptors; glutamate; spatial memory

Mesh:

Substances:

Year:  2014        PMID: 24719089      PMCID: PMC3983795          DOI: 10.1523/JNEUROSCI.5338-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  73 in total

1.  Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP/PS1 mouse model of Alzheimer's disease.

Authors:  Mohammed Filali; Robert Lalonde; Serge Rivest
Journal:  Neuropharmacology       Date:  2011-01-31       Impact factor: 5.250

2.  Transcriptional profiling of small samples in the central nervous system.

Authors:  Stephen D Ginsberg
Journal:  Methods Mol Biol       Date:  2008

3.  Amino acid neurotransmitter deficits in adult Down's syndrome brain tissue.

Authors:  G P Reynolds; C E Warner
Journal:  Neurosci Lett       Date:  1988-11-22       Impact factor: 3.046

4.  Hippocampal cytotoxic lesion effects on species-typical behaviours in mice.

Authors:  Robert M J Deacon; Adam Croucher; J Nicholas P Rawlins
Journal:  Behav Brain Res       Date:  2002-05-14       Impact factor: 3.332

5.  Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists.

Authors:  Alexander M Kleschevnikov; Pavel V Belichenko; Mehrdad Faizi; Lucia F Jacobs; Khin Htun; Mehrdad Shamloo; William C Mobley
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

Review 6.  Cognitive deficits and associated neurological complications in individuals with Down's syndrome.

Authors:  Ira T Lott; Mara Dierssen
Journal:  Lancet Neurol       Date:  2010-06       Impact factor: 44.182

7.  Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.

Authors:  D M Holtzman; D Santucci; J Kilbridge; J Chua-Couzens; D J Fontana; S E Daniels; R M Johnson; K Chen; Y Sun; E Carlson; E Alleva; C J Epstein; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

Review 8.  Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.

Authors:  Chris G Parsons; Albrecht Stöffler; Wojciech Danysz
Journal:  Neuropharmacology       Date:  2007-08-10       Impact factor: 5.250

9.  Selective loss of NMDA receptor NR1 subunit isoforms in Alzheimer's disease.

Authors:  Matthew R Hynd; Heather L Scott; Peter R Dodd
Journal:  J Neurochem       Date:  2004-04       Impact factor: 5.372

Review 10.  Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities.

Authors:  Noemí Rueda; Jesús Flórez; Carmen Martínez-Cué
Journal:  Neural Plast       Date:  2012-05-22       Impact factor: 3.599

View more
  25 in total

1.  Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome.

Authors:  Brian E Powers; Ramon Velazquez; Christy M Kelley; Jessica A Ash; Myla S Strawderman; Melissa J Alldred; Stephen D Ginsberg; Elliott J Mufson; Barbara J Strupp
Journal:  Brain Struct Funct       Date:  2015-12-30       Impact factor: 3.270

2.  Enhanced generation of intraluminal vesicles in neuronal late endosomes in the brain of a Down syndrome mouse model with endosomal dysfunction.

Authors:  Pasquale D'Acunzo; Tal Hargash; Monika Pawlik; Chris N Goulbourne; Rocío Pérez-González; Efrat Levy
Journal:  Dev Neurobiol       Date:  2019-08-01       Impact factor: 3.964

3.  A longitudinal multimodal in vivo molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss.

Authors:  Samuel Chiquita; Mário Ribeiro; João Castelhano; Francisco Oliveira; José Sereno; Marta Batista; Antero Abrunhosa; Ana C Rodrigues-Neves; Rafael Carecho; Filipa Baptista; Catarina Gomes; Paula I Moreira; António F Ambrósio; Miguel Castelo-Branco
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

4.  Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99).

Authors:  Ying Jiang; Yutaka Sato; Eunju Im; Martin Berg; Matteo Bordi; Sandipkumar Darji; Asok Kumar; Panaiyur S Mohan; Urmi Bandyopadhyay; Antonio Diaz; Ana Maria Cuervo; Ralph A Nixon
Journal:  J Neurosci       Date:  2019-05-01       Impact factor: 6.167

5.  Designer receptors enhance memory in a mouse model of Down syndrome.

Authors:  Ashley M Fortress; Eric D Hamlett; Elena M Vazey; Gary Aston-Jones; Wayne A Cass; Heather A Boger; Ann-Charlotte E Granholm
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

6.  Transcriptional dysregulation causes altered modulation of inhibition by haloperidol.

Authors:  Lillian J Brady; Aundrea F Bartley; Qin Li; Laura J McMeekin; John J Hablitz; Rita M Cowell; Lynn E Dobrunz
Journal:  Neuropharmacology       Date:  2016-07-29       Impact factor: 5.250

7.  A pleiotropic role for exosomes loaded with the amyloid β precursor protein carboxyl-terminal fragments in the brain of Down syndrome patients.

Authors:  Rocío Pérez-González; Sébastien A Gauthier; Ajay Sharma; Chelsea Miller; Monika Pawlik; Gurjinder Kaur; Yohan Kim; Efrat Levy
Journal:  Neurobiol Aging       Date:  2019-08-01       Impact factor: 4.673

Review 8.  Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

Authors:  Eric D Hamlett; Heather A Boger; Aurélie Ledreux; Christy M Kelley; Elliott J Mufson; Maria F Falangola; David N Guilfoyle; Ralph A Nixon; David Patterson; Nathan Duval; Ann-Charlotte E Granholm
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

9.  CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation.

Authors:  Melissa J Alldred; Helen M Chao; Sang Han Lee; Judah Beilin; Brian E Powers; Eva Petkova; Barbara J Strupp; Stephen D Ginsberg
Journal:  Hippocampus       Date:  2018-02-12       Impact factor: 3.899

10.  Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD).

Authors:  Melissa J Alldred; Sang Han Lee; Eva Petkova; Stephen D Ginsberg
Journal:  Brain Struct Funct       Date:  2014-07-17       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.